- USD/INR takes a U-turn from two-month high, pressured around daily low at the latest.
- India FinMin official expects V-shaped economic recovery, RBI may cite Omicron fears to avoid repo hike.
- India reports lowest daily infections since May 2020, total active cases dropped to June 2020 levels.
- Upbeat market sentiment weigh on US dollar amid light calendar.
USD/INR struggles to extend the bounce off intraday low around 75.30, down 0.08% on a day during early Tuesday morning in Asia.
The Indian rupee (INR) pair cheers mildly positive sentiment, as well as optimism at home, to pause two-day advances by reversing from October 13 high.
Among the positives, comments from Indian Finance Ministry (FinMin) official, cited by NewsRise, were the major ones to weigh on the USD/INR prices. The Indian diplomat said, “Economy has seen v-shaped recovery, key parameters showing strong rebound.” It’s worth noting that the Indian policymakers are bracing for the listing of the domestic bonds to the global indices and the same keeps the investors at home hopeful enough to favor INR.
Elsewhere, India’s daily coronavirus infections rose by the least since May 2020 while the total active infections slumped to the lowest since June 2020, per official data cited by NewsRise and shared via Reuters.
It should be noted, however, that the Reserve Bank of India (RBI) is likely to mark the South African covid variant, dubbed as Omicron to step back from an anticipated cut in the repo hike. “The Reserve Bank of India will likely hold off on raising its key borrowing and lending rates on Wednesday, as it adopts a cautious tone amid the spread of the Omicron coronavirus variant, economists and market participants said,” per Reuters.
Also weighing on the USD/INR prices is the People’s Bank of China’s (PBOC) measures to safeguard the world’s second-largest economy from the virus woes and Japans’ readiness for record stimulus.
On the other hand, an absence of notable virus-led deaths and expectations of finding a cure to the COVID-19 strain seems to keep the sentiment brighter.
Moving on, a light calendar ahead of Friday’s US Consumer Price Index (CPI) may challenge USD/INR moves but Wednesday’s RBI meeting will be important to watch.
A clear daily break of the 75.20 horizontal resistance, now support comprising highs marked during October-November, keeps USD/INR buyers hopeful to refresh the yearly top beyond 75.65.
Additional important levels
|Today last price||75.3035|
|Today Daily Change||-0.0795|
|Today Daily Change %||-0.11%|
|Today daily open||75.383|
|Previous Daily High||75.4726|
|Previous Daily Low||75.1665|
|Previous Weekly High||75.3298|
|Previous Weekly Low||74.7275|
|Previous Monthly High||75.1908|
|Previous Monthly Low||73.8515|
|Daily Fibonacci 38.2%||75.3557|
|Daily Fibonacci 61.8%||75.2834|
|Daily Pivot Point S1||75.2088|
|Daily Pivot Point S2||75.0346|
|Daily Pivot Point S3||74.9027|
|Daily Pivot Point R1||75.515|
|Daily Pivot Point R2||75.6469|
|Daily Pivot Point R3||75.8211|
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.